As Middle East tensions resurface and futures drop, VIG, VIGI, and FDVV offer dividend growth ETFs combining income with exposure to technology and global equities.
VERAXA Biotech (NASDAQ: VRXA) operates in one of biotechnology’s most active partnering environments, with pharmaceutical companies continuing to commit billions of dollars to differentiated antibody...
Haleon has struck a five-year partnership with Microsoft as it looks to expand its AI transformation using Microsoft's Copilot.
European stocks are outpacing the S&P 500 in 2026, and ArcelorMittal, Arm Holdings, and Novartis are three Euro Stoxx 50 components with index-beating returns.
/AI%20(artificial%20intelligence)/Businessman%20touching%20the%20brain%20working%20of%20Artificial%20Intelligence%20(AI)%20Automation%20by%20Suttiphong%20Chandaeng%20via%20Shutterstock.jpg)
Nvidia’s backing highlights growing confidence in AI-powered biotech stocks.
With U.S. federal debt exceeding 100% of GDP, VXUS and IXUS offer investors international equity exposure as a hedge against rising sovereign risk.
Amgen ($AMGN) is investing an additional $300 million to expand its biologics manufacturing facility in Puerto Rico, bringing its recent commitments to the site to nearly $1 billion as drugmakers increase...
Barchart Research What to Expect from NVS Earnings NVS Generated April 27, 2026 Current Price $144.19 EPS Estimate $$2.11 Consensus Rating Moderate Buy Average Move 2.66% Can Novartis Prove Its Pipeline...
Monday U.S. Featured Earnings Verizon Communications Inc (NYSE:VZ) (Q1) EPS of $1.22, ...
With uncertainty plaguing the market, investors might be more inclined than usual to seek out low-volatility alternatives. These ETFs take multiple approaches.